Royce & Associates’s ResMed RMD Stock Holding History

Royce & Associates’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-47,368	Closed	-$2.33M	–	1368
2014 Q3	$2.33M	Sell	47,368 -965	-2%	-$49.1K	0.01%	976
2014 Q2	$2.45M	Buy	48,333 +1,533	+3%	+$76K	0.01%	1010
2014 Q1	$2.09M	Hold	46,800	–	–	0.01%	1041
2013 Q4	$2.2M	Buy	46,800 +400	+0.9%	+$20.2K	0.01%	1051
2013 Q3	$2.45M	Sell	46,400 -1,200	-3%	-$58.2K	0.01%	1031
2013 Q2	$2.15M	Buy	+47,600	New	+$2.26M	0.01%	1038

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Royce & Associates's RMD Position: Q4 2014 in Review

Royce & Associates sold out of ResMed (RMD) in Q4 2014, closing a stake of 47,368 shares — an estimated $2.33M sold.

Royce & Associates first reported a position in RMD in Q2 2013 and held it in 6 quarters. The position peaked at $2.45M in Q3 2013. 309 funds tracked by Wall St. Rank hold RMD as of Q4 2014.

Royce & Associates reported no remaining ResMed position as of Q4 2014 after selling out during the quarter.
Royce & Associates sold 47,368 ResMed shares in Q4 2014, an estimated $2.33M.
Royce & Associates first reported a position in ResMed in Q2 2013 and held it in 6 quarters.
Royce & Associates's ResMed position peaked at $2.45M in Q3 2013.
309 funds tracked by Wall St. Rank held ResMed as of Q4 2014.

Based on Royce & Associates's 13F filing for Q4 2014, filed 9 Feb 2015.